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CASE REPORT
Malignant mesothelioma is a rare fatal neoplasm
that originates from cells lining the serosal cavi-
ties. Approximately 90–95% of mesotheliomas
arise in the pleural cavity and 5–10% in the peri-
toneal cavity. Rarely, mesothelioma arises in the
pericardium and tunica vaginalis.1 Malignant pleu-
ral mesothelioma predominantly affects men over
the age of 50 years (male/female ratio, 3:1). It is
associated with a long latency period (20–40 years)
between asbestos exposure and eventual expres-
sion of the disease. Malignant pleural mesothe-
lioma usually presents with chest pain, dyspnea,
unexplained unilateral pleural effusion, or other
nonspecific respiratory symptoms. Metastatic dis-
ease is uncommon at the time of initial diagnosis.
When metastases are present, major sites include
the regional lymph nodes, contralateral lung, liver,
adrenal glands and kidneys. Diffuse infiltration
of the peritoneum of the gastrointestinal tract is
common in patients with extensive abdominal
disease at autopsy.2 However, luminal involvement
forming discrete polypoid lesions is very rarely
found at autopsy. Here, we describe an extremely
rare case of duodenal metastasis of malignant
pleural mesothelioma in a 73-year-old man.
Case Report
A 73-year-old man was admitted to our hospital
in December 2005 with symptoms of cough with
pain in the left chest wall. He denied any systemic
underlying disease and occupational exposure to
asbestos. On physical examination, he appeared
to be in good general health and nutritional con-
dition, except for pale conjunctiva. His blood pres-
sure was 116/74mmHg, with a regular pulse rate of
80 beats/min. Breathing sounds were decreased in
the left lung, with dull percussion. The abdomen
was soft but not tender.
Laboratory investigations revealed: hemoglobin
concentration of 9.1 g/dL (normal, 12–16 g/dL),
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mean corpuscular volume of 89.9 fl (normal,
81–92 fl), normal thrombocyte and leukocyte
counts, blood urea nitrogen of 13.2 mg/dL (nor-
mal, 5–25 mg/dL), creatinine of 1.12 mg/dL (nor-
mal, 0.5–1.5 mg/dL), and normal liver enzymes.
Stool occult blood was positive.
Chest radiographs and computed tomography
(CT) showed left hemithorax nodular pleural
thickening, which was suggestive of pleural ma-
lignancy and highly suspicious for pleural malig-
nant mesothelioma (Figure 1). Abdominal CT
revealed no evidence of peritoneal dissemination.
A core biopsy specimen of the pleura demon-
strated proliferation of atypical spindle cells in a
fascicular pattern, with invasion of the underly-
ing skeletal muscle bundles. Brisk mitotic activity
was noted in the high-power fields. Neoplastic
cells were strongly immunoreactive for cytoker-
atin and focally positive for calretinin. Based on
these characteristics, sarcomatoid mesothelioma
was finally diagnosed.
Supplementary inquiry with respect to asbestos
exposure revealed no patient memory of any di-
rect exposure. Further investigation into the cause
of stool occult blood revealed no abnormalities
in the colon. Subsequent esophagogastroduode-
noscopy demonstrated a friable polypoid lesion
and ulceration that involved the second portion
of the duodenum (Figure 2).
Microscopic investigation of the biopsy speci-
men showed interlacing fascicles of spindle cells
in the lamina propria of the duodenum. Immu-
nohistochemical staining was positive for cyto-
keratin and vimentin, but negative for CD34,
CD117 (c-kit) and calretinin. Numerous giant
desmosome-like junctions and long, slender mi-
crovilli were demonstrated ultrastructurally (Figure
3), which was consistent with metastatic sarco-
matoid mesothelioma.
Advanced treatment was not suggested because
of poor performance status and family objections.
Despite supportive care, the patient finally died
as a consequence of pneumonia with septic shock
1 month later.
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Figure 1. (A) Chest radiography and (B) axial contrast-enhanced computed tomography show nodular pleural thickening
(arrows) in the left hemithorax.
Figure 2. Esophagogastroendoscopy shows an ulcerative
polypoid lesion in the second portion of the duodenum.
Mesothelioma with duodenal metastasis
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Discussion
Malignant pleural mesothelioma typically mani-
fests locally, and presentation with metastatic
disease is uncommon. It is a unilateral disease of
the pleura in 95% of cases, and occurs predom-
inantly on the right side (60%). It is aggressive
and characterized by rapid progression and inva-
sion of the intrathoracic structures. Median post-
diagnosis survival is only about 9 months, with
death usually caused by thoracic disease. Such
rapid progression may have contributed to the
previous belief that malignant mesothelioma is a
condition that only manifests locally. In con-
trast, distant metastases from malignant pleural
mesothelioma appear relatively late and are fre-
quently discovered at autopsy. Extensive abdom-
inal involvement is discovered at autopsy in one
third of cases. However, involvement of the gas-
trointestinal lumen alone is exceptional. Reviewing
the English-language literature, we encountered
only five clinical cases of malignant mesothe-
lioma that involved the gastrointestinal lumen
(large bowel, ileum, stomach, duodenal bulb),
from pleural (n=4) and peritoneal (n=1) primary
tumors.3–6 Histologically, four mesotheliomas
were epithelioid and only one was sarcomatoid.
We believe that the present case may be the first
documentation of malignant sarcomatoid me-
sothelioma of the pleura with metastasis to the
duodenum, without imaging evidence of peri-
toneal seeding.
As histologic findings may vary, immunohis-
tochemistry (IHC) and electron microscopy (EM)
are helpful for confirming the diagnosis. IHC has
proven to be quite valuable in the differentiation of
epithelioid mesothelioma from primary pulmo-
nary or metastatic adenocarcinoma.7 In addition
to markers that support a diagnosis of adenocar-
cinoma, including carcinoembryonic antigen,
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Figure 3. (A) Polygonal spindle cells diffusely infiltrate the lamina propria of the duodenum (hematoxylin & eosin [H&E];
original magnification, 10×). (B) The tumor was composed of spindle-shaped cancer cells with mitotic activity (arrow),
arranged focally in a vague fascicular pattern (H&E; original magnification, 40×). (C) Electron micrograph shows numer-
ous giant desmosome-like junctions (arrows) and long, slender microvilli (arrowhead) (original magnification, 6000×).
Leu-M1, thyroid transcription factor-1, Ber-EP4
and B72.3, there are now a number of commer-
cially available antibodies that are reliable markers
of mesothelial differentiation, including calreti-
nin, cytokeratin 5/6, and Wilms’ tumor-1 antigen.
There is no single marker that has sufficiently
high sensitivity and specificity for malignant me-
sothelioma. Both sets of markers tend to be less
helpful in the differential diagnosis of sarcoma-
toid lesions. EM of the epithelioid form has shown
that it is composed of polygonal cells with nu-
merous long surface microvilli, prominent desmo-
somes, and abundant tonofilaments. EM of the
sarcomatoid variant has revealed the presence of
elongated nuclei and copious rough endoplasmic
reticulum. In the present case, the primary lesion
was a malignant pleural sarcomatoid mesothe-
lioma according to the histologic and IHC findings.
The findings from IHC and EM are consistent with
a diagnosis of metastatic sarcomatoid mesothe-
lioma of the duodenum.
Duodenal metastases are most frequently lo-
cated in the periampullary region, followed by the
duodenal bulb. Common manifestations are ab-
dominal pain, nausea, vomiting and gastrointesti-
nal bleeding. In our case, the isolated metastasis
in the second portion of the duodenum appeared
friable, with evidence of ulceration. Diagnosis of
metastatic lesions of the duodenum may be prob-
lematic. The small intestine may show a mass le-
sion, mucosal defect or intussusception, but is
often unremarkable. Abdominal CT may demon-
strate thickening of the wall and folds in the in-
volved segment of the intestine. In our case, the
focally thickened duodenal wall and any peri-
toneal lesion were not identified by abdominal
CT. According to abdominal CT, we could at least
exclude the possibility of primary or secondary
peritoneal lesions. Endoscopic evaluation of the
gastrointestinal tract provides an alternative to
radiographic evaluation and should be considered
when radiographic diagnostic studies are unre-
vealing.8 In a recent report by Kakugawa et al,9
video capsule endoscopy and double-balloon en-
teroscopy revealed multiple protruding lesions,
with central ulceration and bleeding, throughout
the entire small intestine, despite CT, esophago-
gastroduodenoscopy, total colonoscopy and red
blood cell scintigraphy failing to identify any cause
for the gastrointestinal bleeding. In our case, we
did not undertake any advanced procedure to de-
tect other metastatic lesions because the isolated
duodenal lesion revealed by esophagogastroduo-
denoscopy could explain the cause of anemia and
occult blood. However, we must keep in mind
that detailed small-intestinal studies should be
considered if the cause of anemia or occult blood
cannot be ascertained.
In conclusion, it appears reasonable to antici-
pate that, as local control of pleural mesothelioma
improves and survival increases, we will see an
increasing number of patients presenting with
disease that has spread to unusual sites. The pos-
sibility of gastrointestinal tract metastasis should
be considered in the presence of anemia or oc-
cult blood in patients with malignant pleural
mesothelioma.
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